Evidence-Based Medicine Guidelines
Antioxidant treatment for amyotrophic lateral sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antioxidant Treatment for Amyotrophic Lateral Sclerosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis.
Antioxidant treatment for amyotrophic lateral sclerosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis. Accessed June 7, 2023.
Antioxidant treatment for amyotrophic lateral sclerosis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis
Antioxidant Treatment for Amyotrophic Lateral Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 June 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antioxidant treatment for amyotrophic lateral sclerosis
ID - 455370
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
